| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
SkinBioTherapeutics Plc (LSE: SBTX)
SBTX Technical Analysis
5
| As on 13th Feb 2026 SBTX STOCK Price closed @ 12.38 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 18.02 & Strong Sell for SHORT-TERM with Stoploss of 17.49 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SBTXSTOCK Price
| Open | 14.00 | Change | Price | % |
| High | 15.00 | 1 Day | -7.12 | -36.51 |
| Low | 12.13 | 1 Week | -8.62 | -41.05 |
| Close | 12.38 | 1 Month | -4.37 | -26.09 |
| Volume | 108719313 | 1 Year | -3.50 | -22.04 |
| 52 Week High 26.10 | 52 Week Low 12.25 | ||||
LSE UK Most Active Stocks
| ENET | 0.00 | % |
| EQT | 0.04 | -20.00% |
| UKOG | 0.01 | 0.00% |
| HE1 | 0.78 | 41.82% |
| LLOY | 100.40 | -1.95% |
| SYME | 0.00 | % |
| MSMN | 0.02 | 0.00% |
| DEMG | 0.02 | -50.00% |
| TRP | 0.03 | 0.00% |
| SMDS | 582.50 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| SBTX Daily Charts |
SBTX Intraday Charts |
Whats New @ Bazaartrend |
SBTX Free Analysis |
|
|
SBTX Important Levels Intraday
| RESISTANCE | 17.91 |
| RESISTANCE | 16.14 |
| RESISTANCE | 15.04 |
| RESISTANCE | 13.94 |
| SUPPORT | 10.82 |
| SUPPORT | 9.72 |
| SUPPORT | 8.62 |
| SUPPORT | 6.85 |
SBTX Forecast February 2026
| 4th UP Forecast | 22.4 |
| 3rd UP Forecast | 19.19 |
| 2nd UP Forecast | 17.2 |
| 1st UP Forecast | 15.21 |
| 1st DOWN Forecast | 9.55 |
| 2nd DOWN Forecast | 7.56 |
| 3rd DOWN Forecast | 5.57 |
| 4th DOWN Forecast | 2.36 |
SBTX Weekly Forecast
| 4th UP Forecast | 20.09 |
| 3rd UP Forecast | 17.62 |
| 2nd UP Forecast | 16.09 |
| 1st UP Forecast | 14.56 |
| 1st DOWN Forecast | 10.20 |
| 2nd DOWN Forecast | 8.67 |
| 3rd DOWN Forecast | 7.14 |
| 4th DOWN Forecast | 4.67 |
SBTX Forecast2026
| 4th UP Forecast | 42.17 |
| 3rd UP Forecast | 32.62 |
| 2nd UP Forecast | 26.71 |
| 1st UP Forecast | 20.81 |
| 1st DOWN Forecast | 3.95 |
| 2nd DOWN Forecast | -1.95 |
| 3rd DOWN Forecast | -7.86 |
| 4th DOWN Forecast | -17.41 |
SkinBioTherapeutics Plc ( LSE UK Symbol : SBTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SBTX Business Profile
SkinBioTherapeutics plc, a life science company, engages in the research and development of lysates derived from the human microbiome on skin. The company focuses on the development of SkinBiotix technology for use in cosmetic, infection control, and eczema applications. It has an agreement with Croda International Plc for the design and manufacture of a new active cosmetic skincare ingredient based on its SkinBiotix skin microbiome technology; and a research programme with the University of Manchester to investigate and develop microbiome formulations. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Macclesfield, the United Kingdom. Address: 15 Silk House, Macclesfield, United Kingdom, SK11 7QJ
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service